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Neurodevelopmental and psychiatric disorders correspond to a range of 
conditions that affect the developing brain, generating long-term global 
effects, such as autism spectrum disorder (ASD), schizophrenia and attention 
deficit hyperactivity disorder (ADHD) [1]. Those are quite heterogeneous 
conditions that share common features including alterations in the immune 
system and hormonal modulation of T-cell development [2]. 
The brain of a child is in continuous development and does not represent 
a miniature replica of an adult brain. It is constantly undergoing structural and 
neurochemical changes due to the continuous stimulation provided by the 
environment in which it develops. In this context, the immune system plays a 
central role, directly influencing and modulating this highly plastic brain. The 
impact can be varied, depending on the parental genetic/epigenetic 
background, and environmental risk factors [3], affecting neurodevelopmental 
stages during pregnancy, perinatal period or childhood (Figure 1).  
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Neuroimmunomodulation is a field of knowledge that is continuously and 
rapidly advancing, e.g. three decades ago it was considered that the central 
nervous and immune systems worked independently, with little or no 
interactions between them. Recently, the discovery of the central nervous 
system lymphatic vessels [4] suggests that malfunction of the meningeal 
lymphatic vessels could also be involved in neurological disorders.  
Currently, we know that there is a vast interface of communication 
between the brain-gut axis and microbiota [5], involving changes in brain 
barriers permeability [6]. The human microbiome comprises trillions of 
commensal microbes, including bacteria, fungi, and viruses, affecting epigenetic 
mechanisms, metabolic activity, and immune system function. The alterations 
in the balance between the communication of homeostatic systems, such as 
the nervous, endocrine and immune systems, make us more prone to different 
disorders (Figure 2). Although many studies concerning the 
neuroimmunoendocrine  circuitry have emerged in recent years, the potential 
pathways involved in the triggering and pathophysiology of psychiatric and 
neurodevelopmental disorders, as well as the specific role played by 
neuroimmune axes in this process, still require an extensive investigation. 
This might, in turn, reward us with new therapeutic targets and preventive 
strategies for these disorders. 
In this special issue we invited distinguished researchers to discuss 
‘immune subjects’ relevant to the pathophysiology and aetiology of 
neurodevelopmental and psychiatric conditions.  
Liberman et al. provide a comprehensive review of the neuroimmune 
alterations found in several psychiatric disorders in the article ‘Neuroimmune 
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and inflammatory signals in complex disorders of the CNS’. The main topics 
are: (1) peripheral immune findings and depression; (2) ASD and the central 
effects of long-term pro-inflammatory stimuli, including morphological alteration; 
(3) brain repair and the role to microglia, and; (4) the relation between 
neurodegenerative disorders and neuroinflammation. 
The article ‘Intracellular Pathogens Infections and Immune Response in 
Autism’ by Abib et al. focus on the analysis of the clinical findings linking 
perinatal infections and ASD. The central role of IL-6, which has also been used 
to induce preclinical models of ASD in rodents and non-human primates, is also 
investigated. 
In the article ‘Reduced CD4 T lymphocytes in lymph nodes of the mice 
model of autism induced by valproic acid’, Baronio et al. present findings related 
to immune alterations in one of the main models for the study of ASD, with a 
decrease in T cells in the lymph nodes.  
Deckmann et al. present a recollection of the immune findings in the animal 
model of ASD induced by VPA in the article ‘Neuroimmune alterations in autism: 
a translational analysis focusing on the animal model of autism induced by 
prenatal exposure to valproic acid’. Interestingly, they highlight the direct links 
between the model with actual findings in humans with ASD, also providing a 
comprehensive outline on the current literature in the area. 
The extensive findings of immune alterations in patients with ASD place the 
immune system as a potential candidate for therapeutic interventions. In the 
article ‘Immunological Dysfunction in Autism Spectrum Disorder: A Potential 
Target For Therapy’, Marchezan et al. present a comprehensive list of 
interventions targeting the immune system. They also evaluate and analyse the 
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outcomes, providing valuable insights into the pathways that could be further 
explored and the ones that, unfortunately, are not offering promising results. 
Following the recent outbreak of Zika Virus (ZIKV) and its link to congenital 
malformations, Vianna et al. explore the potential relationship between ZIKV 
and ASD. The article ‘ZIKV as a possible risk factor for ASD: 
neuroimmunological aspects’ explores the maternal immune alterations and the 
foetal brain infection induced by ZIKV, and how this could predispose those 
infected to ASD 
Leffa et al. offers an analysis of the evidence linking ADHD to immune 
alterations in the article ‘A review on the role of inflammation in Attention-
Deficit/Hyperactivity Disorder’. They stress that, despite the evidence 
suggesting a strong correlation between ADHD and the immune system, further 
studies are instrumental to determine a causative link. 
In the article ‘The relationship between cytokines and verbal memory in 
individuals with schizophrenia and their unaffected siblings’, Rebouças et al. 
compare the verbal memory of patients with schizophrenia with their unaffected 
siblings and healthy controls. Their scores are analysed and corelated to the 
peripheral immune findings, providing important insights about neuroimmune 
biomarkers in chronic and acute psychotic states. 
Therefore, this special issue addresses the relationship between 
neuroimmunomodulation, developmental and psychiatric conditions, highlighting 
conceptual pitfalls and puzzling new outstanding questions and directions for 
further research. We hope this alternative approach to disorders traditionally 
approached through exclusive neural optics, will be insightful and exciting for 
you readers. Enjoy! 
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Legends of Figures 
Figure 1. Genetic/epigenetic background associated with environmental 
risk factors impacting life. A. Parental background during fertilization: The 
parental genetic background, coupled to epigenetic influences and 
environmental risk factors during pregnancy may contribute to the triggering of 
neurodevelopmental and psychiatric disorders. The impact of an environmental 
risk factor on the outcome is also dependent on particular neurodevelopmental 
windows. B. The influence of genetic and environmental risk factors during 
embryogenesis: The above-mentioned background can influence 
embryogenesis by means of a looping of changes with immunological and 
endocrine responses, which may pass through a pro-inflammatory and pro-
oxidant framework. It is important to point out that the gestational condition 
undergoes changes in the immunological profile to avoid embryonic rejection. If 
the embryo is exposed to an environmental risk factor, associated to the 
particular maternal immune profile, it can have an impact on the neural 
development, with short, medium- and long-term responses, associated to a 
neuroimmunoendocrine fingerprint in the offspring. C. Postnatal timeline: 
Beyond negative influences on embryogenesis timeline, impacts and traumas in 
the first months of life may undergo epigenetic changes, associated with the 
neuroimmunoendocrine fingerprint with consequences throughout life. 
 
Figure 2. The developmental crosstalk after embryonic impact through  
genetic/epigenetic background and environmental risk factor. Growing 
evidence suggests that immune system activation early in life account for 
variability in behavioral and psychiatric disorders in an intricate crosstalk 
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through life, influencing neuro-endocrine systems associated with the stress 
response. The gut-brain axis involves bidirectional communication between the 
central and the enteric nervous systems, interconnected to the microbiome, with 
neural, endocrine and immune links. Immunological changes may also involve 
brain barrier permeability, increased blood cell uptake into the brain, with a 
looping of  neuroinflammation and neuroimmune abnormalities common in 
neurodevelopmental and psychiatric disorders. 
 
